Posted by Michael Wonder on 16 Aug 2016
Medicare negotiating of drug prices may not be the cure to high costs
16 August 2016 - Innovative cost-cutting solutions may help Medicare crimp costs more than negotiating directly with drug makers.
Presidential candidates Donald Trump and Hillary Clinton have said that giving Medicare the ability to negotiate prices directly with drugmakers could yield important savings that firm up Medicare's financial future. However, industry experts are increasingly questioning that thinking. Can Medicare's negotiating might rein in high drug costs, or are there better options?
